• USPSTF Stays Neutral on Global ABI Testing in Asymptomatic PAD

    2 monthes ago - By Medscape

    Finding a lack of evidence on the benefits or harms of ankle-brachial index screening in asymptomatic patients, clinicians are advised to use tools, such as the Pooled Cohort Equations, to estimate CVD risk.
    Medscape Medical News
    Read more ...

     

  • USPSTF: Insufficient evidence to assess benefits, harms of nontraditional CVD risk factors

    2 monthes ago - By Healio

    John T. Wilkins
    Evidence is currently insufficient regarding the benefits and harms of adding ankle-brachial index, high-sensitivity C-reactive protein or coronary artery calcification score to traditional risk assessment for CVD in patients who are asymptomatic, according to a recommendation statement released by the U.S. Preventive Services Task Force and published in JAMA.
    This recommendation statement is an update to the 2009 USPSTF recommendation to assess CHD risk with nontraditional risk factors.
    “The major change in the current recommendation is that the USPSTF evaluated the Pooled
    Read more ...

     

  • USPSTF: CAC, hsCRP, Brachial Index Not Ready for Prime Time

    2 monthes ago - By Medscape

    Citing a paucity of data, the task force balked at recommending for or against coronary calcium scoring, high-sensitivity C-reactive protein, and ankle-brachial index for CVD risk assessment.
    Medscape Medical News
    Read more ...